Paul-Ehrlich-Institut

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

Immunological Medicines for Pigs

Immunological veterinary medicinal products, including vaccines, are authorised for pigs.

Search results 76 to 85 from a total of 85

Name De­scrip­tion Mar­ket­ing Au­tho­ri­sa­tion Hold­er Li­cense Num­ber Li­cense Date An­i­mal Further Information

Suvaxyn Circo + MH RTU

Circovirus-Infektion, Enzootische Pneumonie

Zoetis Belgium S.A., Belgien

EU/2/15/190/001-006 06.11.2015 Schwein

EPAR: Suvaxyn-circo-mh-rtu

Suvaxyn CSF Marker

Klassische Schweinepest

Zoetis Belgium S.A., Belgien

EU/2/14/179/001-002 10.02.2015 Schwein

Suvaxyn M. hyo

Enzootische Pneumonie

Zoetis Deutschland GmbH

175a/92 03.06.1994 Schwein

Suvaxyn MH-One

Enzootische Pneumonie

Zoetis Deutschland GmbH

PEI.V.02689.01.1 01.04.2005 Schwein, Mastschwein

Suvaxyn PRRS MLV

PRRS

Zoetis Belgium S.A., Belgien

EU/2/17/215/001-003 24.08.2017 Schwein

EPAR: Suvaxyn PRRS MLV

Syvac Ery Parvo

Parvovirose, Rotlauf

Laboratorios Syva, S.A., Spanien

PEI.V.12131.01.1 21.09.2022 Schwein

UNISTRAIN PRRS

PRRS

Laboratorios Hipra S.A., Spanien

PEI.V.11596.01.1 13.03.2013 Schwein

VEPURED

Ödemkrankheit

Laboratorios Hipra, S.A., Spanien

EU/2/17/214/001-005 17.08.2017 Schwein

EPAR: VEPURED

Versiguard Rabies

Tollwut

Zoetis Deutschland GmbH

PEI.V.03351.01.1 03.05.2006 Hund, Katze, Frettchen, Pferd, Schwein, Ziege, Schaf, Rind

Zylexis

Paramunisierung, Stimulierung unspezifischer Immunmechanismen

Zoetis Deutschland GmbH

PEI.V.02388.01.1 05.11.2001 Hund, Katze, Pferd, Rind, Schwein

Disclaimer

The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.

The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.

As of: PEI announcement No. 520 in BAnz AT 22.08.2024 B6.

Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)

Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.

If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.

Updated: 22.08.2024